Capricor Therapeutics, Inc. (OTCBB:CAPR), a biotechnology company - TopicsExpress



          

Capricor Therapeutics, Inc. (OTCBB:CAPR), a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases, today announced positive data from the laboratory of Eduardo Marbán, M.D., Ph.D., Capricor’s Scientific Advisory Board Chairman and the Director of the Cedars-Sinai Heart Institute. The abstract was presented at the Late Breaking Basic Science Posters and Reception at the American Heart Association’s Scientific Sessions 2014 on November 17, 2014.
Posted on: Tue, 18 Nov 2014 20:54:32 +0000

Trending Topics



Recently Viewed Topics




© 2015